Tumors often overexpress enzymes that synthesize fatty acids, but the requirement for fatty acid synthesis in tumor growth is unclear. A new fatty acid–synthesis inhibitor blunts lung tumor growth in mice, which implicates this process as a targetable liability.
This is a preview of subscription content, log in via an institution to check access.
References
DeBerardinis, R.J. & Chandel, N.S. Sci. Adv. 2, e1600200 (2016).
Swinnen, J.V., Brusselmans, K. & Verhoeven, G. Curr. Opin. Clin. Nutr. Metab. Care 9, 358–365 (2006).
Svensson, S.J. et al. Nat. Med. 22, 1108–1119 (2016).
Wakil, S.J. & Abu-Elheiga, L.A. J. Lipid Res. 50 (Suppl.), S138–S143 (2009).
Beaty, N.B. & Lane, M.D. J. Biol. Chem. 258, 13051–13055 (1983).
Steinberg, G.R. & Kemp, B.E. Physiol. Rev. 89, 1025–1078 (2009).
Kamphorst, J.J. et al. Proc. Natl. Acad. Sci. USA 110, 8882–8887 (2013).
Padanad, M.S. et al. Cell Rep. 16, 1614–1628 (2016).
Abu-Elheiga, L. et al. Proc. Natl. Acad. Sci. USA 102, 12011–12016 (2005).
Bild, A.H. et al. Nature 439, 353–357 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.J.D. is an advisor for Agios Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Kim, J., DeBerardinis, R. Blocking fatty acid synthesis reduces lung tumor growth in mice. Nat Med 22, 1077–1078 (2016). https://doi.org/10.1038/nm.4195
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4195
- Springer Nature America, Inc.